inrebic.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot / ✔
BingBot / ✔
BaiduSpider / ✔
YandexBot / ✔ 
User-agent: * Disallow: Sitemap:
Meta Tags
Title Myelofibrosis Treatment - INREBIC®
Description Be IN Command Ask your doctor about INREBIC, and take an active approach to your primary or INREBIC® (fedratinib) is a myelofibrosis treatment option for intermediate-2 or high-risk myelofibrosis (MF). Please see Indication and Important Safety Information including Boxed
Keywords N/A
Server Information
WebSite inrebic faviconinrebic.com
Host IP 45.60.170.161
Location United States
Related Websites
Site Rank
More to Explore
inrebic.com Valuation
US$5,106,892
Last updated: 2023-05-12 13:07:49

inrebic.com has Semrush global rank of 2,072,553. inrebic.com has an estimated worth of US$ 5,106,892, based on its estimated Ads revenue. inrebic.com receives approximately 589,257 unique visitors each day. Its web server is located in United States, with IP address 45.60.170.161. According to SiteAdvisor, inrebic.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$5,106,892
Daily Ads Revenue US$4,715
Monthly Ads Revenue US$141,422
Yearly Ads Revenue US$1,697,060
Daily Unique Visitors 39,284
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
inrebic.com. A 298 IP: 45.60.170.161
inrebic.com. A 298 IP: 45.60.150.161
inrebic.com. NS 86400 NS Record: ns-1520.awsdns-62.org.
inrebic.com. NS 86400 NS Record: ns-1892.awsdns-44.co.uk.
inrebic.com. NS 86400 NS Record: ns-816.awsdns-38.net.
inrebic.com. NS 86400 NS Record: ns-109.awsdns-13.com.
inrebic.com. TXT 300 TXT Record: google-site-verification=u-iNzmwofvHxrXWJxoIDg-O0n9xXMc9fyPxKAAngUss
inrebic.com. TXT 300 TXT Record: c645133d2fe243d99e9aa78e8a13e32d
HtmlToTextCheckTime:2023-05-12 13:07:49
Prescribing Information Medication Guide Indication BMS Access Support ® BMS Connect --> Visit Website for Healthcare Professionals Indication --> × INREBIC ® (fedratinib) is a prescription medicine used to treat adults with certain types of myelofibrosis (MF). It is not known if INREBIC is safe and effective in children. Indication Prescribing Information This site is intended for US audiences only. About INREBIC Taking INREBIC Side Effects Resources & Support Prescribing Information Medication Guide BMS Access Support ® Visit Website for Healthcare Professionals X This website is best viewed using the horizontal display on your tablet device. This website is best viewed using the vertical display on your mobile device. Be IN Command Ask your doctor about IN REBIC , and take an active approach to your primary or secondary myelofibrosis journey. LEARN MORE Not an actual patient. Be IN Command Ask your doctor about IN REBIC , and take an active approach to your primary or
HTTP Headers
HTTP/1.1 301 Moved Permanently
Location: https://inrebic.com/
Content-Length: 0
Connection: close

HTTP/2 301 
date: Sat, 18 Dec 2021 08:31:41 GMT
content-type: text/html; charset=iso-8859-1
set-cookie: AWSALBTG=CZ54exWVdOV/eQB4+5mZw0/mXIvdRfBzA76646m2FJzvmJLlvdOoxWXQrA5nnaCxBlskSxn50dbdpo4ljeCbLCPuvxWOV/CZW04bwUpPStMS9PE7omV4fWJKwaMnv3RRDazdT9e9T1zsB4fJb69O/SXb/hfqzNsLBQSFCYHmvtpVz5foOmU=; Expires=Sat, 25 Dec 2021 08:31:41 GMT; Path=/
set-cookie: AWSALBTGCORS=CZ54exWVdOV/eQB4+5mZw0/mXIvdRfBzA76646m2FJzvmJLlvdOoxWXQrA5nnaCxBlskSxn50dbdpo4ljeCbLCPuvxWOV/CZW04bwUpPStMS9PE7omV4fWJKwaMnv3RRDazdT9e9T1zsB4fJb69O/SXb/hfqzNsLBQSFCYHmvtpVz5foOmU=; Expires=Sat, 25 Dec 2021 08:31:41 GMT; Path=/; SameSite=None; Secure
server: Apache
location: https://www.inrebic.com/
set-cookie: AWSALBAPP-0=_remove_; Expires=Sat, 25 Dec 2021 08:31:41 GMT; Path=/
set-cookie: AWSALBAPP-1=_remove_; Expires=Sat, 25 Dec 2021 08:31:41 GMT; Path=/
set-cookie: AWSALBAPP-2=_remove_; Expires=Sat, 25 Dec 2021 08:31:41 GMT; Path=/
set-cookie: AWSALBAPP-3=_remove_; Expires=Sat, 25 Dec 2021 08:31:41 GMT; Path=/
set-cookie: visid_incap_2613599=wO83qyS2Ts6XIaOMsmg2EGycvWEAAAAAQUIPAAAAAAC1JZ06imd44rkZpZ5jOwLp; expires=Sat, 17 Dec 2022 12:55:38 GMT; HttpOnly; path=/; Domain=.inrebic.com
set-cookie: incap_ses_1464_2613599=IYAMP7qI0lzqOPL1VyxRFGycvWEAAAAAqPOE3Egv+uH4zV2dBxBdbQ==; path=/; Domain=.inrebic.com
x-cdn: Imperva
x-iinfo: 1014-127527353-127504544 pNNN RT(1639816300197 0) q(0 0 0 1) r(1 1) U6

HTTP/2 200 
date: Sat, 18 Dec 2021 08:31:42 GMT
content-type: text/html; charset=UTF-8
set-cookie: AWSALBTG=MdTeXS0brfwYgT24QPtKS66xJOe+t7r5PZiWcVcGc+/JGdMIqaPMCjSWWu2nQLBjr+ARx2g7ty3jzVsko+eQw7MZA7TyKkaXGDnx7SVqJGD/ckd6zQl2j1w4K+lWhMkU6guEkfws2pDrKU/nRYG1o8D19QsKfWqozVK5Nz98UY7gmmLllpo=; Expires=Sat, 25 Dec 2021 08:31:41 GMT; Path=/
set-cookie: AWSALBTGCORS=MdTeXS0brfwYgT24QPtKS66xJOe+t7r5PZiWcVcGc+/JGdMIqaPMCjSWWu2nQLBjr+ARx2g7ty3jzVsko+eQw7MZA7TyKkaXGDnx7SVqJGD/ckd6zQl2j1w4K+lWhMkU6guEkfws2pDrKU/nRYG1o8D19QsKfWqozVK5Nz98UY7gmmLllpo=; Expires=Sat, 25 Dec 2021 08:31:41 GMT; Path=/; SameSite=None; Secure
server: Apache
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
x-xss-protection: 1; mode=block
set-cookie: AWSALBAPP-0=_remove_; Expires=Sat, 25 Dec 2021 08:31:42 GMT; Path=/
set-cookie: AWSALBAPP-1=_remove_; Expires=Sat, 25 Dec 2021 08:31:42 GMT; Path=/
set-cookie: AWSALBAPP-2=_remove_; Expires=Sat, 25 Dec 2021 08:31:42 GMT; Path=/
set-cookie: AWSALBAPP-3=_remove_; Expires=Sat, 25 Dec 2021 08:31:42 GMT; Path=/
set-cookie: visid_incap_2613599=3XhR8/DaTZGspAXILO+KUGycvWEAAAAAQUIPAAAAAAADB4MJ3MIIhJeMswCGLiof; expires=Sat, 17 Dec 2022 12:55:38 GMT; HttpOnly; path=/; Domain=.inrebic.com
set-cookie: incap_ses_1464_2613599=N2MTcL7ytwEIOfL1VyxRFG2cvWEAAAAAXjY24oizlilC1k2GOz61gg==; path=/; Domain=.inrebic.com
x-cdn: Imperva
x-iinfo: 13-116148404-116139107 pNNN RT(1639816300308 0) q(0 0 0 0) r(11 11) U6
inrebic.com Whois Information
Domain Name: INREBIC.COM
Registry Domain ID: 2261820687_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.corporatedomains.com
Registrar URL: http://cscdbs.com
Updated Date: 2021-05-06T05:12:50Z
Creation Date: 2018-05-10T16:21:26Z
Registry Expiry Date: 2022-05-10T16:21:26Z
Registrar: CSC Corporate Domains, Inc.
Registrar IANA ID: 299
Registrar Abuse Contact Email: domainabuse@cscglobal.com
Registrar Abuse Contact Phone: 8887802723
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS-109.AWSDNS-13.COM
Name Server: NS-1520.AWSDNS-62.ORG
Name Server: NS-1892.AWSDNS-44.CO.UK
Name Server: NS-816.AWSDNS-38.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-12-18T07:30:23Z <<<

Copyright © 2022 WebZZ.US 0.0230